SAB Biotherapeutics Inc (SABS): Market Capitalization
SAB Biotherapeutics (SABS) revenues are based on US government orders and hospital contracts for the development of immunotherapy, with a market capitalization of 0.29. This price chart, which clearly demonstrates changes, confirms the potential of the DiversitAb platform, which enables the synthesis of polyclonal antibodies without donor involvement. Business resilience is bolstered by a stable staff of biochemists and the active recruitment of experts in rare pathologies.
Comprehensive metric breakdowns and analytics for SAB Biotherapeutics Inc (SABS)
- current price and projected stock value:
- stock exchange capitalization data:
- issuer book value statistics:
- business debt structure and liquidity details:
Total Debt to Capital SAB Biotherapeutics|SABS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital SAB Biotherapeutics|SABS - Company Aggregate Debts|Debt to Book Capitalization Ratio SAB Biotherapeutics Inc|SABS - Company Long-Term Loans and Borrowings|Company Short-Term Debt SAB Biotherapeutics|Quick Ratio sabbiotherapeutics.com
- business earnings and investment ratios data:
SABS - Net Profit|Future Profit SAB Biotherapeutics|SABS - Company Value to Net Income|Forward P/E Multiple SAB Biotherapeutics, Inc|SABS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SAB Biotherapeutics Inc|SABS - Operating profit before deduction of amortization|Earnings per share for the last twelve months SAB Biotherapeutics|SABS - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months sabbiotherapeutics.com|SABS - Earnings growth in current year|Net earnings per share growth forecast for next year SAB Biotherapeutics
Fundamental company analysis:SABS (SAB Biotherapeutics, Inc.)
Cold chain reliability during antibody transportation determines the operational resilience of SAB Biotherapeutics. The company's total market capitalization represents the aggregate market value of all outstanding shares. The dynamics of this metric reflect market confidence in the business's scalability. Analyzing the total market capitalization curve allows for the separation of speculative noise from fundamental growth. The current trend serves as the basis for determining the asset's fair value.
Key competitors
Market Capitalization ARGX (argenx)|Market Capitalization BioNTech Inc. BNTX|Abivax S.A. - Market Capitalization|ADMA: Market Value|Protagonist Therapeutics (PTGX) - Market Value|IMVT - Market Capitalization|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT - Market Value|Market Capitalization Aerovate Therapeutics Inc JBIO|ACRS: Market Capitalization|kyvernatx.com (KYTX) - Market Capitalization|TLSA (Tiziana Life Sciences Ltd) - Market Capitalization|Market Value CABA|Market Valuation VTYX (Ventyx Bio)|THTX (Theratechnologies, Inc) - Market Value|Market Capitalization AVTX (Avalo Therapeutics, Inc)|eledon.com - Market Value|Agenus Inc. - Market Capitalization|Market Capitalization Climb Bio Inc. CLYM|Zura Bio (ZURA) - Market Value|Market Value aTyr Pharmaceuticals (ATYR)|Market Valuation ADAG|IMA (Ikena Oncology, Inc.) - Market Value|Market Capitalization STTK|EQ (equilliumbio.com) - Market Value|Market Capitalization CNTB (Connect Biopharma Holdings Limited)|Immunic Therapeutics (IMUX) - Market Value|ATRA - Market Value|Market Value IFRX (InflaRx N.V.)|XFOR: Market Capitalization|Adicet Bio, Inc. (ACET) - Market Capitalization|Market Value Celularity Inc|INmune Bio Corporation - Market Valuation|Market Capitalization BRNS|KZR - Market Value|Akari Therapeutics Plc - Market Valuation|Market Capitalization Enlivex Therapeutics Ltd ENLV|QTTB: Market Valuation|GeoVax Corp - Market Value|EDSA: Market Capitalization|IBIO - Market Capitalization|CARM (Carisma Therapeutics Inc) - Market Capitalization|Market Valuation XTL Biopharmaceuticals Ltd (XTLB)|Market Value Bolt Biotherapeutics (BOLT)|Market Capitalization hcwbiologics.com|Market Value Aptevo Therapeutics Inc. APVO|Market Capitalization aimimmuno.com (AIM)|Aditxt Corp - Market Capitalization|GRI - Market Capitalization|XRTX: Market Capitalization|HIND (Vyome Therapeutics) - Market Value|Market Value Revelation Biosciences|indaptusrx.com (INDP) - Market Capitalization|Market Value Scinai Immunotherapeutics Ltd. (SCNI)|CALI: Market Valuation|Market Capitalization AFMD (Affimed N.V.)|Market Value ALLK|HOOKIPA - Market Capitalization|IGMS - Market Capitalization|iTeos Therapeutics, Inc. (ITOS) - Market Value|Ocean Biomedical Inc - Market Value|Market Value TC BioPharm (Holdings) PLC|Market Valuation Third Harmonic Bio Inc (THRD)
